Securities Lawsuit Filed Against Alto Neuroscience, Inc.

Strategic Insights -

Alto Neuroscience, Inc. investors who were affected by alleged securities fraud may be entitled to compensation. A class action securities lawsuit has been filed on behalf of investors who purchased Alto common stock in connection with the Company's initial public offering in 2024 or acquired the company's securities between February 2, 2024, and October 22, 2024. The lawsuit alleges that Alto's product pipeline, ALTO-100, was less effective in treating major depressive disorder than the company had led investors to believe, and that the company's public statements were materially false and misleading.

Key Takeaways:

  • A class action securities lawsuit has been filed on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud.
  • The lawsuit seeks to recover losses on behalf of investors who purchased Alto common stock in connection with the Company's initial public offering in 2024 or acquired the company's securities between February 2, 2024, and October 22, 2024.
  • The lawsuit alleges that Alto's product pipeline, ALTO-100, was less effective in treating major depressive disorder than the company had led investors to believe.
  • The lawsuit also alleges that the company's public statements about its product pipeline and business prospects were materially false and misleading.
  • Investors may be entitled to compensation without payment of any out-of-pocket costs or fees.
  • The deadline to request that the Court appoint you as lead plaintiff is September 19, 2025.
  • Levi & Korsinsky, LLP has extensive expertise representing investors in complex securities litigation and has secured hundreds of millions of dollars for aggrieved shareholders.

Statistics:

  • The lawsuit covers investors who purchased Alto common stock in connection with the Company's initial public offering in 2024 (February 2, 2024).
  • The lawsuit also covers investors who acquired Alto securities between February 2, 2024, and October 22, 2024.
  • The deadline to request that the Court appoint you as lead plaintiff is September 19, 2025.
  • Levi & Korsinsky, LLP has secured hundreds of millions of dollars for aggrieved shareholders in the past 20 years.
  • Levi & Korsinsky, LLP has been ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States for seven years in a row.

Sources:

  • GLOBE NEWSWIRE, "Levi & Korsinsky, LLP Notifies Investors of Class Action Lawsuit Against Alto Neuroscience, Inc. (ANRO) (GLOBE NEWSWIRE, 2025)"